Lam Research Corporation | Large-cap | Technology

Financial Overview

Latest Annual: 2024

Income Metrics

Revenue 14.9B
Gross Profit 7.1B 47.32%
Operating Income 4.3B 28.73%
Net Income 3.8B 25.68%
EPS (Diluted) $2.90

Balance Sheet Metrics

Total Assets 18.7B
Total Liabilities 10.2B
Shareholders Equity 8.5B
Debt to Equity 1.20

Cash Flow Metrics

Operating Cash Flow 5.0B
Free Cash Flow 4.3B

Revenue & Profitability Trend

Lam Research Income Statement From 2020 to 2024

Metric 2024 2023 2022 2021 2020
Revenue 14.9B 17.4B 17.2B 14.6B 10.0B
Cost of Goods Sold 7.9B 9.7B 9.4B 7.8B 5.4B
Gross Profit 7.1B 7.8B 7.9B 6.8B 4.6B
Operating Expenses 2.8B 2.6B 2.5B 2.3B 1.9B
Operating Income 4.3B 5.2B 5.4B 4.5B 2.7B
Pre-tax Income 4.4B 5.1B 5.2B 4.4B 2.6B
Income Tax 532.4M 598.3M 587.8M 462.3M 323.2M
Net Income 3.8B 4.5B 4.6B 3.9B 2.3B
EPS (Diluted) $2.90 $3.32 $3.28 $2.69 $1.51

Income Statement Trend

Lam Research Balance Sheet From 2020 to 2024

Metric 2024 2023 2022 2021 2020
Assets
Current Assets 12.9B 13.2B 12.3B 11.7B 10.9B
Non-Current Assets 5.9B 5.6B 4.9B 4.2B 3.7B
Total Assets 18.7B 18.8B 17.2B 15.9B 14.6B
Liabilities
Current Liabilities 4.3B 4.2B 4.6B 3.5B 3.2B
Non-Current Liabilities 5.9B 6.4B 6.4B 6.3B 6.2B
Total Liabilities 10.2B 10.6B 10.9B 9.9B 9.4B
Equity
Total Shareholders Equity 8.5B 8.2B 6.3B 6.0B 5.2B

Balance Sheet Composition

Lam Research Cash Flow Statement From 2020 to 2024

Metric 2024 2023 2022 2021 2020
Operating Activities
Net Income 3.8B 4.5B 4.6B 3.9B 2.3B
Operating Cash Flow 5.0B 5.2B 3.0B 3.2B 1.9B
Investing Activities
Capital Expenditures - - - - -
Investing Cash Flow 26.1M -33.0M 1.2B 422.4M -40.8M
Financing Activities
Dividends Paid -1.0B -907.9M -815.3M -727.0M -656.8M
Financing Cash Flow -4.1B -2.9B -4.7B -4.3B 540.6M
Free Cash Flow 4.3B 4.7B 2.6B 3.2B 1.9B

Cash Flow Trend

Lam Research Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 25.52
Forward P/E 21.45
Price to Book 12.36
Price to Sales 6.84
PEG Ratio 21.45

Profitability Ratios

Profit Margin 27.19%
Operating Margin 33.09%
Return on Equity 53.14%
Return on Assets 17.29%

Financial Health

Current Ratio 2.45
Debt to Equity 47.15
Beta 1.66

Per Share Data

EPS (TTM) $3.59
Book Value per Share $7.41
Revenue per Share $13.24

Peer Financial Comparison

Company Market Cap P/E Ratio P/B Ratio ROE Profit Margin Debt/Equity
lrcx 117.2B 25.52 12.36 53.14% 27.19% 47.15
Applied Materials 138.0B 20.92 7.28 36.37% 24.06% 35.18
KLA 113.2B 31.18 28.28 104.10% 31.99% 152.05
Teradyne 14.0B 24.75 5.02 21.55% 19.86% 2.46
Entegris 11.4B 36.97 3.04 8.65% 9.57% 108.16
Nova 6.9B 35.31 6.97 23.87% 28.46% 24.00

Financial data is updated regularly. All figures are in the company's reporting currency.